Arkolith/Insider Trading/AVTE/Form 4

Noyes Timothy P

CHIEF EXECUTIVE OFFICER, DirectorAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$300K
Net Open-Market Flow
-$300K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Sell(S)3K$31.02$88K1K
Apr 1, 2024Sell(S)1K$31.95$32K0
Apr 1, 2024Option exercise(M)10K$2.14$21K10K
Apr 1, 2024Sell(S)5K$28.96$130K5K
Apr 1, 2024Sell(S)2K$29.90$49K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)10K—$0373K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-010138) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML